BeneVir Biopharm, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
BeneVir Biopharm, Inc. is a biotechnology research company focused on cancer immunotherapy. Its product concept involves viruses engineered to specifically infect and destroy cancer cells while also triggering the immune system to attack tumors elsewhere in the body. The technology employs a stealth approach that helps these viruses avoid rapid immune clearance, allowing them to continue activity against cancer. By combining direct tumor killing with immune activation, the approach aims to enhance therapeutic outcomes. Based in Rockville, Maryland, BeneVir operates in the biotechnology research sector and has a relatively small to mid-sized team. Its work is directed at developing virus-based immunotherapies for cancer, with the goal of informing researchers and pharmaceutical developers pursuing new cancer treatments.